Patents Examined by Aaron J Kosar
  • Nutraceutical dietary supplement
    Patent number: 11324246
    Abstract: A nutraceutical dietary supplement formulation for the treatment of joint pain and discomfort may include astaxanthin powder; boswellia serrate gum resin extract; hyaluronic acid; undenatured type II (UC-II) collagen; eggshell membrane collagen powder; turmeric root extract; white willow bark extract; cayenne pepper extract; and Cat's Claw bark powder. The formulation may be formed into capsules for delivery to a user, wherein a therapeutically effective dosage of the formulation may be included in each capsule.
    Type: Grant
    Filed: February 9, 2021
    Date of Patent: May 10, 2022
    Inventor: Michael Bowditch Weis
  • Dietary supplement
    Patent number: 11324756
    Abstract: A method of forming a dietary supplement can include steps of creating a composition of matter comprising sakae naa and CDP; and providing the composition of matter in a liquid or solid form. Providing the composition of matter can include filling a container with the composition of matter.
    Type: Grant
    Filed: April 10, 2020
    Date of Patent: May 10, 2022
    Inventor: James Peter Morrissette
  • Compositions, methods, and kits for cleansing and moisiurizing
    Patent number: 11318086
    Abstract: Compositions, methods, and kits for cleansing, moisturizing, soothing, cooling, such as those, for example, that may be used to cleanse, moisturize, soothe, and cool the body or portions thereof.
    Type: Grant
    Filed: March 2, 2020
    Date of Patent: May 3, 2022
    Inventors: Brandon Joseph Karam, Jessica Karam Oley
  • Plant extract for skin infections
    Patent number: 11318182
    Abstract: A method for treatment of at least one fungal infection of a mammal includes administering a composition consisting of grinded garlic, ginger, papaya seed, clover bud, tamarind and coconut oil components extracted by 95% ethanol and kept in darkness for about four days.
    Type: Grant
    Filed: January 8, 2021
    Date of Patent: May 3, 2022
    Inventor: Eyob Wanorie Wallano
  • Dietary supplement
    Patent number: 11318146
    Abstract: A method of forming a dietary supplement can include steps of creating a composition of matter comprising sakae naa and kava; and providing the composition of matter in a liquid or solid form. Providing the composition of matter can include filling a container with the composition of matter.
    Type: Grant
    Filed: April 7, 2020
    Date of Patent: May 3, 2022
    Inventor: James Peter Morrissette
  • Dietary supplement
    Patent number: 11318147
    Abstract: A method of forming a dietary supplement can include steps of creating a composition of matter comprising sakae naa and GPC; and providing the composition of matter in a liquid or solid form. Providing the composition of matter can include filling a container with the composition of matter.
    Type: Grant
    Filed: April 10, 2020
    Date of Patent: May 3, 2022
    Inventor: James Peter Morrissette
  • VE-cadherin expression promoting agent and/or integrin ?5 expression promoting agent
    Patent number: 11311585
    Abstract: The purpose of the present invention is to provide a substance related to the stabilization of capillary blood vessels. This invention is based on the discovery that an extract from a plant selected from the group consisting of Calendula officinalis, Siberian ginseng, and Cistanche salsa increases gene expression of VE-cadherin or integrin ?5.
    Type: Grant
    Filed: November 15, 2018
    Date of Patent: April 26, 2022
    Assignee: Shiseido Company, Ltd.
    Inventors: Kentaro Kajiya, Yuuko Matsumoto
  • Clear skin supplement and medicinal composition for acne
    Patent number: 11311595
    Abstract: There is disclosed a clear skin supplement/medicinal component for acne comprising: an orally administered dosage comprising of between about 3000-9000 mg of the Chinese medicinal composition comprising by ratio: around 3.8-7.6% of each of Prunus persica, Carthamus tinctorius, Angelica dahurica, Gleditsia sinensis, Viola yedoensis, Paeonia suffruticosa and gardenia jasminoides; around 5.7-7.6% of each of Oldenlandia diffusa and Scutellaria baicalensis; around 3.8-5.7% of Salvia miltiorrhiza; around 2.5-5.7% of Phellodendron amurense; around 2.5-7.6% of Gentiana scabra; and around 0-7.6% of each of Taraxacum mongolicum and any one of Lonicera japonica/Rhizoma Coptidas/Sophora flavescens.
    Type: Grant
    Filed: December 20, 2018
    Date of Patent: April 26, 2022
    Inventor: Vivian Tam
  • Medicated honey and method of preparation thereof
    Patent number: 11304983
    Abstract: Medicated honey and method of preparing the same are disclosed herein. The disclosed honey is obtained by feeding honeybees with bee-feed obtained from medicinal plants. The medicated honey disclosed herein is such that it has anti-oxidant and anti-cancer properties. The embodiments disclosed herein may be instrumental in strengthening the immune system, as an anti-cancer agent and as an anti-oxidant.
    Type: Grant
    Filed: September 26, 2018
    Date of Patent: April 19, 2022
    Assignee: Muniyal Ayurvedic Research Centre
    Inventor: M Vijayabhanu Shetty
  • Method for treating glioblastoma multiforme
    Patent number: 11298392
    Abstract: The present invention relates to a method for treating glioblastoma multiforme including administering a Chinese medicine composition to a subject in need thereof; wherein the Chinese medicine composition is an extract of a first mixture including Boswellia sacra, Commiphora molmol, Angelica sinensis, Ligusticum striatum, Rehmannia glutinosa, Paeonia veitchii, Prunus persica, and Carthamus tinctorius.
    Type: Grant
    Filed: September 3, 2020
    Date of Patent: April 12, 2022
    Inventor: Da-Tong Ju
  • Compositions and methods useful in treatment of lower urinary tract symptoms, benign prostatic hyperplasia, erectile dysfunction and other diseases or symptoms
    Patent number: 11291703
    Abstract: The invention relates to therapeutic compositions, solid oral dosage forms, and methods for treating, preventing, or alleviating lower urinary tract symptoms (LUTS), benign prostatic hyperplasia (BPH), erectile dysfunction (ED), urinary incontinence, bladder obstruction, overactive bladder (OAB), underactive bladder, interstitial cystitis, prostatitis, bladder and prostate inflammation, prostate fibrosis or pelvic pain. The therapeutic compositions can comprise cranberry powder enriched in cranberry seeds or cranberry seed meal.
    Type: Grant
    Filed: October 23, 2019
    Date of Patent: April 5, 2022
    Assignee: Naturex Inc.
    Inventors: Emilie Annie Claudie Fromentin, Douglas Andrew Klaiber, Daniel David Souza
  • Composition for preventing or treating metabolic diseases containing artemisiae capillaris herba and citrus unshiu peel complex extracts as active ingredients
    Patent number: 11285188
    Abstract: The present disclosure relates to a composition for preventing or treating metabolic diseases, the composition containing Artemisiae capillaris Herba and Citrus unshiu Peel complex extracts as active ingredients. Specifically, in the Artemisiae capillaris Herba and Citrus unshiu Peel complex extracts according to the present disclosure, the content of ingredients useful for prevention of metabolic diseases including obesity is much higher than in extracts obtained only from Artemisiae capillaris Herba. In addition, when a high-fat diet mouse model is administered the complex extracts, the levels of total cholesterol, LDL, and triglycerides in the blood are reduced. Accordingly, the complex extracts of the present disclosure may be used as a composition or functional material for preventing or treating metabolic diseases including obesity, hyperlipidemia, and hypercholesterolemia.
    Type: Grant
    Filed: November 7, 2019
    Date of Patent: March 29, 2022
    Assignee: Medicare Pharmaceuticals Inc.
    Inventors: Do Hyun Na, Jin Hwan Jun, Kyung Pyo Kang
  • Antithrombotic composition containing and
    Patent number: 11273196
    Abstract: The present invention relates to an antithrombotic composition including Polygonum cuspidatum Sieb. et Zucc. and Cinnamomum cassia Blume as active ingredients, and preferably includes an extract obtained by mixing Polygonum cuspidatum Sieb. et Zucc. and Cinnamomum cassia Blume in a weight ratio of 1:2-2:1 and extracting the mixture. The composition of the present invention is highly effective in antithrombotic effects, identified as a platelet aggregation inhibitory effect, a thrombosis inhibitory effect, a thrombosis-delaying effect, and the like, and thus can be used as an effective herbal-medicine-based agent for preventing or treating thrombosis, an antithrombotic health food, and the like.
    Type: Grant
    Filed: September 20, 2018
    Date of Patent: March 15, 2022
    Assignees: NATIONAL INSTITUTE FOR KOREAN MEDICINE DEVELOPMENT, NOVMETAPHARMA CO., LTD.
    Inventors: Hyo Jung Kim, Sun Gun Kim, Jai Hyun So, Hwa Dong Lee, Hye Ryung Kang
  • Antimicrobial and synergistic phytochemical composition, its preparation and applications
    Patent number: 11272711
    Abstract: The innovations provides an antimicrobial and synergistic phytochemical composition, consisting of two active ingredients (FZ and YC). This innovation also consists of formulation processes and its applications to fungi, bacteria and/or virus-caused plant diseases such as citrus Huanglongbing, grape downy mildew, strawberry gray mold etc. This innovation combines two ingredients (FZ and YC) with different modes of action, dramatically improving plant inducible acquired resistance. Therefore, this composition dramatically enhances the control efficacy of plant diseases caused by fungi, bacteria or virus, expands the antimicrobial spectrum and promotes the plant growth.
    Type: Grant
    Filed: September 28, 2016
    Date of Patent: March 15, 2022
    Assignee: PURPANA (BEIJING) TECHNOLOGIES CO., LTD.
    Inventors: Daisong Tuo, Fukang Zhan, Xinyuan Xu, Liquan Sun, Chen Zou, Dan Zhu
  • Nutraceuticals for the prevention, inhibition, and treatment of SARS-CoV-2 and associated COVID-19
    Patent number: 11266707
    Abstract: Disclosed herein are methods of treating or preventing complications associated with a SARS-CoV-2 infection, comprising: administration of a combination comprising: a) Green Tea and/or extract thereof; b) Blueberry and/or extract thereof; c) Nigella sativa and/or extract thereof; and d) broccoli and/or extract thereof in an amount and frequency sufficient to treat or prevent complications associated with said SARS-CoV-2 infection.
    Type: Grant
    Filed: May 4, 2020
    Date of Patent: March 8, 2022
    Assignee: Therapeutic Solutions International, Inc.
    Inventors: Thomas E Ichim, Timothy G Dixon
  • Immunomodulatory composition to treat and/or prevent COVID-19 illness
    Patent number: 11260097
    Abstract: A novel process for extraction of the bioactive phytochemicals from herbs to provide a composition that boost antiviral innate immune response and induce interferon secretion in a host affected by COVID-19 illness and in need for such immunomodulatory treatment.
    Type: Grant
    Filed: July 6, 2020
    Date of Patent: March 1, 2022
    Assignee: COVImmune Pharma LLC
    Inventors: Nedaa Abdul-Ghani Nasif Al Jasim, Noor Z. Ahmed
  • Black rice sprouting liquid having anti-inflammatory effect and manufacturing method thereof
    Patent number: 11246901
    Abstract: Disclosed are a black rice sprouting liquid having an excellent anti-inflammatory effect through low-temperature treatment and room-temperature treatment of water used when black rice is sprouted, and a manufacturing method of the black rice sprouting liquid. The black rice sprouting liquid is obtained by performing low-temperature treatment on water used when black rice is sprouted in an open container at a temperature ranging from 1° C. to 5° C. for 1 day to 10 days, and then performing room-temperature treatment on the resulting water in the open container at a temperature ranging from 10° C. to 30° C. for 30 days to 210 days.
    Type: Grant
    Filed: March 20, 2019
    Date of Patent: February 15, 2022
    Assignees: WELLBEINGGO CO., LTD.
    Inventors: Sung Hyun Kim, Jung Ae Jun
  • Metalloenzyme inhibitor compounds
    Patent number: 11247981
    Abstract: The instant invention describes compounds having metalloenzyme modulating activity, and methods of treating diseases, disorders or symptoms thereof mediated by such metalloenzymes.
    Type: Grant
    Filed: January 6, 2020
    Date of Patent: February 15, 2022
    Assignee: Mycovia Pharmaceuticals, Inc.
    Inventors: William J. Hoekstra, Robert J. Schotzinger, Stephen W. Rafferty
  • Apparatus and method for plant extraction
    Patent number: 11248189
    Abstract: An apparatus and a method for plant extraction are disclosed. The apparatus of the present invention comprises an extraction module, a separating module and a reservoir. The method essentially includes plant material preparing, decarboxylating, active components extracting and separating. By using liquid tetrafluoroethane as the solvent in the apparatus of the present invention, the active components of the plant material are efficiently extracted under low pressure extraction and high pressure extraction conditions.
    Type: Grant
    Filed: January 6, 2020
    Date of Patent: February 15, 2022
    Inventor: George Stantchev
  • Method for checking and controlling the mammalian lactic acid fermentation process/aerobic glucose fermentation metabolic pathway in mammalian organism
    Patent number: 11236381
    Abstract: The method for qualitative and quantitative detecting of the extend of use and the correct process flow of the mammalian aerobic glucose fermentation metabolic pathway (mam-aGF) in a mammalian individual is characterized in that the enzyme TKTL1 is used as indicator and target molecule and the structural and/or functional parameter of said TKTL1 in a biological sample of said individual (patient) are taken as indication for the qualitative and quantitative run of the mam-aGF in the cells and/or tissue of said individual (patient). In combination with the use of inhibitors and activators of the mam-aGF the method is further suitable for checking and controlling the mam-aGF in an individual (patient).
    Type: Grant
    Filed: May 28, 2010
    Date of Patent: February 1, 2022
    Inventor: Johannes Coy